Multiple Myeloma: Autologous Stem Cell Transplant in an aging population

Abstract

Autologous stem cell transplant (ASCT) is the standard-of-care for eligible patients with multiple myeloma. While there is no universally accepted age cutoff for ASCT, limited data are available for older patients particularly those over 75 years old. To further investigate this matter, we performed a retrospective chart review of patients between the ages of 75-78 years old, with newly diagnosed MM patients from the years 2012-2018 that were referred to Washington University School of Medicine.